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a b s t r a c t 
Magnetic resonance spectroscopy (MRS) is an advanced biochemical technique used to identify metabolic 
compounds in living tissue. While its sensitivity and specificity to chemical imbalances render it a valu- 
able tool in clinical assessment, the results from this modality are abstract and difficult to interpret. With 
this design study we characterized and explored the tasks and requirements for evaluating these data 
from the perspective of a MRS research specialist. Our resulting tool, SpectraMosaic, links with upstream 
spectroscopy quantification software to provide a means for precise interactive visual analysis of metabo- 
lites with both single- and multi-peak spectral signatures. Using a layered visual approach, SpectraMosaic 
allows researchers to analyze any permutation of metabolites in ratio form for an entire cohort, or by 
sample region, individual, acquisition date, or brain activity status at the time of acquisition. A case study 
with three MRS researchers demonstrates the utility of our approach in rapid and iterative spectral data 
analysis. 
© 2020 The Author(s). Published by Elsevier Ltd. 































Magnetic resonance spectroscopy (MRS) is an in vivo non-
nvasive biochemical technique used to estimate the concentra-
ions of certain small molecules, known as metabolites, in a tissue
egion. When paired with high structural resolution MR imaging
MRI), it has shown clinical potential for improving diagnosis
nd treatment monitoring of numerous diseases and disorders
f the central nervous system [1] . However, its clinical adoption
emains limited. Translation from the metabolite signals acquired
rom MRS into clinically useful biomarkers is an open challenge
n spectroscopy research. Optimization and tuning of parameters
or consistent, isolated metabolite acquisition is one such area ofThis article has been certified as Replicable by the Graphics Replicability Stamp 
nitiative: http://www.replicabilitystamp.org 
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erns of the subtle disease effects on multiple metabolites [2] . In
his paper, we explore the application of visualization techniques
o identify ratios and patterns of multiple metabolites. 
While recent technology improvements in MRS acquisition have
nhanced data quality and resolution [3] , visualization of MRS data
emains a largely unexplored area. MR spectroscopy produces a
astly different readout than MR imaging. Rather than a greyscale
mage of recognizable anatomical structures over many voxels, it
cquires an abstract spectrum per single voxel. This spectrum con-
ists of a series of peaks (resonances) that represent signal intensi-
ies as a function of frequency, as depicted in Fig. 1 . Metabolites
ay consist of single peaks, as in the case of N-acetylaspartate
NAA), or multiple peaks, as in Creatine (Cr). Most tools used to
uantify single voxel spectral data, e.g., LCModel [4] produce only
udimentary visual output, such as the spectral graph in Fig. 1 .
ecognizing the metabolites that correspond to these graphs is
hallenging. Although it is important to see the spectral graph as a
eans of quality assurance, metabolite concentrations are the mostunder the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Fig. 1. Plot of the typical visual output for spectral quantification by LCModel, with 
processed data and model (overlayed smooth curve). Structural localization and an- 


































































































clinically relevant output from this method. These concentrations
are most often output to a simple table in standard domain tools.
This does little to advance interpretation, understanding, or to fa-
cilitate rapid comparison of metabolites between acquisitions. 
This paper expands upon our previous design study [5] in
building a general tool for the interactive visual analysis of all per-
mutations of spectral metabolites, in ratio form, for a small cohort.
While we previously emphasized rapid visualization of metabolite
ratios directly from spectral input data, this work allows visualiza-
tion of complete, and more complex, metabolic signatures via an
integrated pipeline with Tarquin [6] , an open source spectral quan-
tification tool. Our specific contributions include: 
1. We provide a detailed review of MRS data characteristics and
abstraction of spectral analysis tasks identified from domain ex-
pert collaboration. 
2. We present a refined pipeline that integrates spectral quantifi-
cation and fitting to allow multi-peak metabolite analysis. 
3. Our visual exploratory analysis tool provides an extended inter-
face for linking of structural, spectral, and patient data, includ-
ing group creation and uncertainty communication. 
4. We introduce a tiered system of visual encodings depicting lay-
ers of aggregated metabolite ratios that can be partitioned by
key attributes. 
5. We present a clinical case study and feedback from three MR
spectroscopy research experts. 
Using SpectraMosaic, MR spectroscopy researchers are able to
rapidly identify patterns at different layers that may be of interest
for deeper clinical exploration. 
2. Related work 
A key challenge in visualizing spectroscopy data is that each
spectrum is in itself a multivariate dataset. We draw inspiration
from tools such as InSpectr [7] , which utilizes multiple linked
views and comparative visualization techniques [8] from multi-
modal data sources (x-ray computed tomography and x-ray flu-
oroscopy) to provide insights into composition of a multivari-
ate sample. SpectraMosaic similarly combines imaging techniques
(MRS and MRI), but for a different domain and with a differ-
ent focus. Isosurface similarity maps defined by Bruckner and
Möller [9] were applied to spectra in Spectral Similarity Maps, an
extension of the Inspectr framework [10] . In this approach, corre-
lations between spectra are shown as an intensity map. We adopt
a similar concept in our tool, but rather than mapping energy cor-
relation we instead map metabolite ratios. Prior visualization approaches for MRS data have been lim-
ted to the analysis and visualization of a subset of metabolites
t a time. SDDS (scale driven data spheres) presented by Feng
t al. [11] provide a 3D representation of metabolites within a
oxel. This application was later extended to include scatter and
arallel coordinate plots for a subset of metabolites [12] . Spec-
raMosaic remains in the abstract visualization space, but allows
omparison of all metabolite ratios. Nunes et al. [13] presented a
isual analysis framework combining ComVis [14] and MITK [15] .
rushing and linking mechanisms allow for the definition of a bi-
logical target volume with its corresponding metabolite values.
owever, this work was developed specifically for radiotherapy
reatment visualization. Retention of spectra was not the focus of
he application and it provided limited functionality for metabolite
omparison. SpectraMosaic extends the flexibility of metabolite ra-
io calculations, and displays additional MRS data attributes (spa-
ial, individual, temporal, and brain activity status) in an overview
nd detail visual representation. Marino and Kaufman [16] imple-
ented direct volume rendering (DVR) to represent male prostate
natomy from MRI data combined with PET and MRS in prostate
umor delineation. However, this application was focused on a sin-
le metabolite ratio, and could only present an individual in a sin-
le time slice. SpectraMosaic retains an abstract visualization for-
at, but offers broader insights into metabolite relationships over
ime and between individuals. Jawad et al. [17] developed a system
or the analysis of segmented brain tissue composition to identify
he metabolic signatures of brain tumors—this tool was optimized
or multivoxel data, and focused on statistical outcome measure-
ents. SpectraMosaic works at a more generalized level in spec-
ral analysis. Further work by Jawad et al. [18] presented an ap-
roach for the comparative analysis of single voxel spectroscopy
n cohort data, focusing primarily on violin and parallel coordinate
lots to convey spectral metabolite relationships. Our approach
ses a similar range of data inputs and processing tools. How-
ver, our tool focuses on simultaneous comparison of all metabo-
ite ratios, using a nested visual design linking multiple MRS data
lements. 
First introduced by Bertin [19] , numerous solutions have lever-
ged small related graphics series to visualize multivariate data.
e base SpectraMosaic on this concept, but extend this by in-
luding a second layer of nested visual encodings. This is inspired
y A tom [20] , a grammar for unit visualizations where individ-
al data items are represented by unique visual marks (units) in
 visual encoding system. PivotTable, subsequently trademarked by
icrosoft and extended by Polaris [21] , enables exploration and
nalysis of multidimensional data with the flexibility to modify vi-
ual encodings, graphics, and table configuration for visualization.
lemm et al. [22] built on this concept for linked visualization of
mage-centric heterogeneous cohort data. Our approach is related
n that we allow on-the-fly reconfiguration of our matrix inputs.
lthough the cohorts our application focuses on are not large, we
hare similar considerations with heterogeneous and multivariate
ata inputs. 
While our prior iteration of the SpectraMosaic application fo-
used on the rapid analysis of single-peak metabolites directly
rom spectral graphs [5] , this work expands the tool to allow full,
recise spectral analysis in an integrated pipeline with robust MR
pectroscopy quantification tools. This permits analysis of metabo-
ites with more complex metabolic signatures; these are encoded
o bar and box plots for ease of interpretation. We further increase
he practical usability of the tool with new facilities for analysis
roup creation and additional means for conveying the underly-
ng data distribution. These features arose from additional working
essions and discussions with spectroscopy researchers. 































































































































(  . Background 
MRS is an advanced spectroscopic technique used to non-
nvasively describe the biochemical composition of living tissue.
hile MRI shows the spatial distribution of atomic nuclei with
igh spatial resolution, MRS trades spatial resolution for detailed
hemical information, using the same hardware. For example,
here MRI may be used to identify the extent of a tumor, MRS
an help to identify the type of tumor [23] . For each measured
oxel, MRS produces a spectrum of signal intensity as a function
f frequency. Intensity peaks at different resonance frequencies are
escribed as chemical shifts. These chemical shifts, expressed in
arts per million (ppm), arise from fundamentally different nu-
lear properties of the chemical structures being measured, and
epresent metabolites in the acquired voxel [24] . The most com-
only measured signal comes from hydrogen atoms; this is known
s proton MRS ( 1 H-MRS). This technique is capable of detecting
etabolites in concentrations 50,0 0 0 times lower than that of fat
r water as imaged in conventional MRI. 
MRS acquisition techniques include single voxel spectroscopy
SVS) or chemical shift imaging (CSI). CSI is essentially a slab of
ultiple smaller single voxels. It covers a much larger spatial area
han SVS, but suffers from a reduced signal-to-noise ratio. CSI pro-
uces a low-resolution image for each metabolite, being in that
ay similar to conventional MRI, while SVS is more abstract and
annot be visualised in a conventional way. Since SVS acquisition
echniques afford more detailed spectra for analysis, we focus our
ork on this technique. The majority of acquisitions by our col-
aborators are collected at single time points, i.e., in longitudinal
tudies, but may also be captured as time-resolved concentrations
ithin a single examination, i.e., functional studies. In the latter
pproach the subject can also be asked to perform tasks, such as
apping fingers during the acquisition (active brain state), and al-
ernately resting (resting brain state). 
Following acquisition, data are output to a vendor-specific for-
at that contains raw data and a header file containing all exper-
mental parameters. Subsequent preprocessing and quantification
teps follow to map spectral peak intensities to metabolite con-
entrations in the measured voxel. In a final fitting step, a model
ased on prior information is fit to the acquired spectrum; in
any approaches, this is effectively a linear combination of ba-
is sets consisting of simulated or measured metabolite signatures.
etabolite concentrations are typically calculated relative to a sta-
le reference, often water or creatine. This allows for a direct com-
arison of relative metabolite concentrations, assuming the same
cquisition hardware and protocols are used. While a more com-
rehensive discussion of all steps is beyond the scope of this pa-
er, interested readers can refer to Stagg et al. [25] for a de-
ailed overview. A number of existing tools can be used to perform
hese steps: LCModel [4] is one such widely-used commercial tool,
hile jMRUI [26] , TARQUIN [27] , SIVIC [28] , OXSA [29] , and Gan-
et [30] offer open source solutions. Equipment manufacturers also
upply basic tools to facilitate simple analyses on the scanner con-
ole. Our collaborators typically use LCModel or Tarquin; we utilize
arquin in our pipeline for its ease of use and open availability.
he output from these steps includes the experimental parameters
sed for the acquisition as well as the fitted data and quantifica-
ion information for each metabolite. 
. Task and requirement analysis 
We developed SpectraMosaic over the course of one year. We
et weekly with our domain collaborators, two of whom are
oauthors of this paper. Collaborator backgrounds included two
D/PhDs in radiology, eight PhD researchers in MR imaging, and
hree MR engineers. The weekly meetings went through three dis-inct phases. The first phase focused on domain evaluation, iden-
ification of key challenges and where visualisation could poten-
ially help overcome them. Ultimately, the output from this phase
as agreement on core tasks and requirements. The second phase
xplored the design space for these tasks/requirements with dis-
ussion and interface prototypes. These were refined and narrowed
own to a single option. Our third phase reviewed and refined an
lpha application. Basic use case testing alongside individual and
roup evaluation feedback ultimately helped us settle on the ver-
ion we present in this paper. 
.1. Task analysis and abstraction 
We frame the analysis tasks identified in phase one of our col-
aboration in the context of Brehmer and Munzner’s multi-level
ypology of abstract visualization tasks [31] . This abstraction was
seful for our development process, as it allowed us to more ob-
ectively frame the challenges experienced by our colleagues. These
asks form a generalized workflow shown in Fig. 2 . The first step,
ata discovery, provides a general overview of the input compo-
ents for spectral analysis. Following user selection of components
or analysis, a data production step calculates ratios from all inputs.
atio comparison and summarization follows. 
T1: Data discovery . The first set of tasks relates to data con-
umption for discovery and verification of key MRS data aspects
 Fig. 2 (A)). Spectra, anatomical reference images, and associated
ubject data are reviewed together in an initial overview step. Re-
earchers visualize spectral graphs to establish a general sense of
he data quality and to form initial hypotheses. Supplemental pa-
ameter information, such as the echo time (TE), during the acqui-
ition can be used to verify validity of experimental comparisons.
esearchers additionally validate their assumptions about the spec-
ral graph against its sample location. This serves two purposes:
1) as a second quality assurance measure to check whether the
ata were sampled in the correct region, and (2) to provide initial
alidation for graph differences between spatial regions. This is be-
ause a normal spectrum in one area of the brain may be aberrant
n another region with a different tissue composition [25] . 
T2: Selection and filtering . Following an overview, researchers
ext select and filter the data ( Fig. 2 (B)). In both medical and clin-
cal research studies our collaborators often wish to select a subset
f spectra or metabolites for further analysis for a variety of dif-
erent reasons. For instance, researchers may wish to look only at
he variation in metabolite concentration ratios for a single time
cquisition in a longitudinal cohort study, e.g., pre-operative pa-
ients in a tumor cohort, or to analyze only female subjects within
 study. Furthermore, some metabolites may be uninteresting to
nclude for certain clinical studies, e.g., lipids and macromolecules
re not usually relevant outside of certain oncological studies [25] ,
nd are useful to exclude on–demand. 
T3: Data production . Spectra can vary considerably between ac-
uisitions. This can occur due to different acquisition parameter
ettings or simply between different scanners. Ratios and corre-
ations calculated from metabolite concentrations are two stan-
ard methods to understand spectroscopy data [32] . The use of
atios to determine metabolite concentrations is a core critical
ask for any MRS application for two reasons, (1) as a method to
orrect for inhomogeneity across the sample and (2) to account
or varying tissue composition. Following selection of interesting
etabolites for analysis, a data derivation step takes as input the
arquin–processed and quantified metabolite values and outputs
he metabolites in ratio form ( Fig. 2 (C)). 
T4: Comparison and summarization . Following data derivation,
esearchers then wish to summarize and compare metabolite ratios
 Fig. 2 D). For example, researchers studying oxygen deprivation
hypoxia) in newborns are interested in comparing the metabolic
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Fig. 2. Typical task flow for MRS data analysis. Users begin with data discovery (A) to review spatial voxel position, associated spectral graphs, and relevant acquisition 
parameters. (B) continues with data selection and filtering, where spectral voxels of interest are selected and divided into groups. Data production (C) calculates all possible 
ratios of selected metabolites, e.g., Glutamine (Gln) to N-acetylaspartate (NAA). In (D) ratios are compared and summarized between, e.g., Gln/NAA for different patients or 

















































































a  differences between healthy and hypoxic newborns. This can be
achieved by evaluating ratios of the same metabolites between
both groups, e.g., NAA healthy vs. NAA hypoxic. Futhermore, re-
searchers would like to understand the metabolic profile of hy-
poxic newborns on a spatial and individual level. For instance, the
basal ganglia region of the brain is known to be sensitive to oxy-
gen deprivation, so it is clinically relevant to compare this region
to a less sensitive region. Within a given region of interest re-
searchers then wish to compare individuals to identify clinically
relevant outliers in order to answer questions such as “How does
Lactate/Choline compare for Patient X versus Y?” Moreover, oxygen-
deprived newborns who survive often experience developmental
disabilities later in life. Longitudinal MRS studies allow researchers
to understand how the metabolic profiles of affected individu-
als change over time relative to healthy individuals. In a differ-
ent scenario, researchers studying schizophrenia are interested in
comparing the metabolic profiles of individuals when their brains
are active relative to their resting brain state. Different metabolites
present in different concentrations in these states, and identifica-
tion of these differences may help progress understanding of this
disorder. 
Following comparison of interesting metabolite ratios, re-
searchers often wish to refine their hypotheses and revisit
metabolic input data. This task sequence then repeats, following
an iterative analytical approach to hypothesis exploration and ver-
ification in MRS data. 
4.2. Design requirements 
Following the identification of tasks important for our collabo-
rators in MRS analysis, we developed the design requirements for
our application. First, on a technical and infrastructure level, our
colleagues often switch between hospital workstations while ac-
cessing sensitive patient data. Thus, for practical utility it is critical
to provide a tool that enables a machine-independent workflow ( R1 )
that adheres to patient data restrictions ( R2 ). 
As discussed in T3 , for a combined analysis of spectra acquired
from different scanners, or with different acquisition settings, it
is necessary to calculate metabolite ratios ( R3 ). Furthermore, as
implied by T1 and T2 , visual linking between input data (voxel
placement, spectral graph, patient- and acquisition-specific infor-
mation) and calculated metabolite ratios is important for many anal-
ysis questions ( R4 ). For our collaborators, the most important pa-
tient and scanner-specific information to retain include patient age,
gender, and echo time (TE). Based on the types of questions outlined in T4 , users must be
ble to compare metabolite ratios of interest ( R5 ). This should be ac-
omplished for any permutation through four key attributes: spa-
ial region, individual, time point, and brain activity state . Addition-
lly, appropriate mechanisms to compare ratios over time as well
s between spatial regions and individuals are critical for longitu-
inal or single-run studies. Furthermore, for functional MRS stud-
es it is important to support comparison of metabolite ratios in an
ctive relative to a resting brain state. 
. SpectraMosaic workflow and interface 
We provide an overview of the SpectraMosaic interface in Fig. 3 .
ollowing an offline processing step, data are loaded into the web
ool ( Fig. 3 (A)). Data of interest for analysis can be explored, se-
ected, and added ( Fig. 3 (B)–(D)) to a spectral ratio heatmap for
eeper inquiry and hypothesis verification ( Fig. 3 (E)). A legend
rovides information on the encodings used in the tool ( Fig. 3 (F)).
 table below the heatmap summarizes salient acquisition infor-
ation ( Fig. 3 (G)). 
Data processing and loading . We first perform an offline pro-
essing step that automates spectral processing and quantifica-
ion from Tarquin and MATLAB [33] . We utilize MATLAB to pro-
ess the structural imaging files, which includes patient data de-
dentification ( R2 ). The resulting output contains a structural image
o localize the voxel sample, the spectral graph, quantified metabo-
ites, and associated metadata; these data remain semantically
inked in the visual tool. We use a custom data format because
he DICOM standard is not universally or consistently adopted for
RS data. 
Visual inspection of voxel positioning and spectral graphs . Fol-
owing data loading ( Fig. 3 (A)), the spatial voxel overview panel
 Fig. 3 (B)) is used to review the spectral graph, associated anatom-
cal image, and included metadata for each acquisition. This panel
onsists of a set of images for each patient. In each structural im-
ge, a fuchsia rectangle indicates the voxel sample region for the
RS acquisition ( Fig. 3 (B1)). To the left, a position selector consists
f small filled nodes, each of which indicates an acquisition for
he selected patient. Using the standard CPK color convention for
tomic elements [34] , we represent 1 H spectral metabolites with
 white-filled node. A light gray bar behind the disks shows the
ctive selection image, while the node becomes filled in fuchsia
o indicate image linkage to a spectrum that is selected in the
pectral heatmap panel ( Fig. 3 (B2)). Users can access different im-
ges via these position nodes or time acquisition nodes (horizontal
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Fig. 3. SpectraMosaic application workflow overview. Raw spectral data are first processed in an offline step (A), then loaded into the application. In (B) the user visualizes 
the anatomical image with voxel placement for each acquisition (B1) and the associated spectral graph (B2). In (C) users may create custom groups for analysis. Metabolites 
may be selected (D) for analysis from custom or preset groups in a drop-down list, and selections assigned to the x- or y-axis of a ratio heatmap (E). The ratio heatmap 
is divided into a cell grid (E1) based on the number of metabolite inputs to each axis. Detailed inspection of a cell (E2) shows the ratios in a series of nested glyphs 
representing spatial region, individual, individual brain state, and individual time acquisitions. A legend at the right provides a reference for heatmap glyphs and colors (F). 















































xis). A selected node shows the structural image with localized
oxel, associated spectral graph, and supplemental metadata, such
s TE setting, patient age and gender, stored with that voxel ( R4 ).
hese data are stored hierarchically, where each voxel sample with
patial information is first sorted by individual identifier and asso-
iated metadata, then by time of acquisition, and finally by brain
ctivity state during the acquisition. 
Group creation and metabolite selection . Following visual inspec-
ion of voxel position and spectral graphs, the user may then cre-
te custom groups of spectral voxels for subsequent analysis ( T3 )
n the Voxel Group Overview panel ( Fig. 3 (C)). Custom groups may
e edited at any time. Membership in a custom group is listed
n the metadata table at the bottom right region of the interface
 Fig. 3 (G)). Our application additionally creates preset groups for
ach echo time, spatial region, individual, brain state, and time
oint. These may be immediately accessed in a drop-down list in
he Metabolite panel ( Fig. 3 (D)). 
Following a group selection from the metabolite drop-down list,
ll quantified metabolites from the offline processing step are dis-
layed. Users then have the option of adding all metabolites in the
ist to the x-axis, y-axis or both axes of a spectral ratio heatmap lo-
ated to the right of this list ( Fig. 3 (E)). Alternatively, only a subset
f metabolites may be added to the heatmap axes. Groups may beexibly added or removed from either axis at any time. Metabo-
ites populate along heatmap axes in alphabetical order; we dis-
ussed a number of ordering options with our domain collabora-
ors, settling on this ordering method for consistency and pattern
ecognition between studies. 
Ratio exploration . Following loading of metabolite groups onto
ach axis, we determine ratios for all metabolite permutations for
isplay in the heatmap panel ( Fig. 3 (E)). This serves as the pri-
ary visualization component of our tool, as shown in Fig. 3 (E)
nd which is described in detail in Section 6 . In this view, users
an compare average ( Fig. 3 (E1)) or individual metabolite ratios
t different levels of detail ( R5 ). Users may interactively expand
 cell to reveal key attribute details ( Fig. 3 (E2)), as inspired by
ertifier [35] . The background of the cell remains visible behind
ndividual ratio elements for all expansions to preserve context
f the aggregated value during navigation. This subtle context
reservation was deemed useful by experts in our development
rocess. 
A legend at the far right ( Fig. 3 (F)) serves to indicate hue
nd glyph meaning. Hovering over a cell or glyph correspondingly
ighlights linked data elements in fuchsia, including the associated
pectral graph, patient anatomical image, and associated metadata
 R4 ), as depicted in Fig. 3 G. 
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Fig. 4. Box and bar plots encode metabolite concentrations (tier 1 visual encoding). 
(A) utilizes bars where height encodes the concentration of each metabolite for a 
single spectral input. (B) is utilized for two to four spectral inputs on an axis, where 
height encodes the median value and whiskers encode the minimum and maximum 
metabolite concentration values, respectively. A box plot (C) is utilized for five or 































































r  6. Spectral ratio heatmap 
In the heatmap panel we divide MRS data elements into tiers
of visual priority ( R3–R5 ): 
Tier 1 Quantified spectral data 
Tier 2 Derived spectral data 
Tier 3 Spectral metadata 
Tier 1 has primary importance; it consists of relative metabolite
concentrations which are the result of pre-processing and quan-
tification steps from the raw spectral acquisition. Tier 2 comprises
the complete set of metabolite ratios. It is used for comparison be-
tween user-defined groups as well as the following key attributes:
spatial region, individual, brain activity state, and time point. Spa-
tial region indicates the voxel sample position within the brain.
Individual refers to a given patient included in the analysis. Time
indicates either the number of separate spectral acquisitions per-
formed on an individual over a study period, as in a longitudinal
study, or recorded metabolite values within an acquisition session,
as in a time-resolved MRS study. Finally, brain activity state indi-
cates if the subject was in an active (task-explicit) state or rest-
ing (task-negative) state during signal acquisition. Tier 3 includes
metadata important for context and selection that are unnecessary
to include as explicit encodings in the visualization: gender, age,
and acquisition settings can have varying impact on the resulting
concentrations and ratios of metabolites [25,36] . 
Tier 1 encoding: Visual perception research has shown that en-
coding position along a common axis is the most effective visualFig. 5. In nested ratio calculations, the cell background (A) is first mapped to color bas
metabolites on the y -axis. Within the cell (B), the value of each input metabolite for all p
for each spatial region. Within a spatial region, the average of each metabolite is compa
time, takes a single metabolite input for both the numerator and denominator. hannel for communicating quantitative information [37] . Box plots
re a simple, ubiquitous and descriptive means of visually encoding
tatistical information about a dataset [38] . Since each MRS spec-
rum is essentially a multivariate set, where each metabolite is a
ariable, each metabolite in the spectrum then is tied to its own
et of unique statistical information. We chose box plots over vio-
in [39] or summary plots [40] to visualize tier 1 data, as our goal
ith this tier is to provide clean, quickly readable insight to the
nput value range. Our use of box plots is additionally inspired by
lumenschein et al. [41] , who used bars to encode aggregate di-
ensions in their work on table visualization. Bars and box plots
re additionally well-recognized and easy to interpret; use of ele-
ents that were familiar to our target user group was an impor-
ant design consideration. Furthermore, since box plots are only
pplicable when a dataset consists of five or more members, we
ntroduce three variations depending on the number of inputs as
llustrated in Fig. 4 . For any of these variations, we first flatten the
oxel hierarchy described in the spatial overview panel, and split
he data into one voxel array per axis. In each array, we calculate
he mean for each metabolite. In the case of a single spectral input,
e use design variation A, which utilizes bars only, where height
ncodes the concentration of each metabolite ( Fig. 4 (A)). We calcu-
ate median, minimum, and maximum for two or more metabolite
alues on an axis. This corresponds to variation B, where height
ncodes the median value and whiskers encode the minimum and
aximum metabolite concentration value, respectively ( Fig. 4 (B)).
or five or more metabolites on an axis we additionally calculate
he interquartile range. The box and whisker plot in variation C is
tilized in this case, and shows the median, first and third quar-
iles, and the minimum and maximum value ( Fig. 4 (C)). 
Tier 2 encoding: Overview. In tier 2 , we visualize ratios between
he mean along the x - and y -axes in a heatmap matrix ( R5 ), as
hown in Fig. 3 (E). This effectively trades the low spatial resolu-
ion of MRS data for abstract resolution, focusing on biochemical
oncentrations in detail for a small region of interest. Each cell
hows the aggregate ratio of the metabolite on the x -axis posi-
ion to the corresponding y-axis metabolite, for instance mean Glu-
amine (Gln)/mean N-acetylaspartate (NAA), as illustrated in Fig. 5 .
e map the ratio value to a diverging red-blue colormap [42] in-
ide each heatmap cell, as this color scheme is a familiar sight to
ur collaborators. In instances where the ratio is less than 1, we
nvert the ratio and switch the sign. To obtain a cleanly symmet-
ic, divergent mapping structure we drop all values by 1 so theed the average of input metabolites on the x-axis divided by the average of input 
atients, at all time and brain state collections, is averaged and compared as a ratio 
red for each patient, then for the brain state of each patient. The innermost step, 
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individ.Case region time ptstate visual individ.Case region time ptstate visual
Fig. 6. Key tier 2 visual attributes include: brain spatial region, individual, brain state, and time point. We assign a unique glyph to each of these four attributes. Brain state 
is defined as active or resting; in absence of a classification we assume a resting state. All remaining three attributes may have single or multiple recordings. This produces 
























































s  iagonal of the heatmap matrix is 0, rather than 1. Our aim is to
raw attention to large input differences; this was identified as im-
ortant for spectroscopy researchers. Red indicates a higher x -axis
etabolite input while blue indicates a higher y -axis metabolite
nput. Equivalent inputs map to white. If an input value is 0, we
ap the cell color to dark grey. We originally thought to exclude
uch values from the heatmap, but on further discussion with our
ollaborators felt these were useful to include in order to preserve
ontext. This heatmap view provides a means to visualize other-
ise undetectable patterns in a rapid overview. To aid color in-
erpretation and perception, our application includes a colormap
egend to the right of the heatmap ( Fig. 3 (F)). 
Tier 2 encoding: Attributes. Through a series of group interviews
nd individual shadowing sessions to the MR scanners we iden-
ified that, following an overview of all aggregated metabolite ra-
ios, researchers are most interested in comparing and summariz-
ng ( T4 ) individual metabolites. For a given metabolite ratio, re-
earchers first are interested in comparing brain spatial regions , as
his can provide the most context for understanding ratio differ-
nces, e.g., in a tumor cohort study where voxels are acquired in
he tumor region and in a healthy region of the brain. With spatial
ontext, researchers can easily compare ratios between individuals .
ssessing brain activity state is then most relevant in the context of
he individual. After comparing the difference in active vs. resting
rain state for an individual, the researcher may review the differ-
nce in these values over a cohort. Similarly, time points are best
ssessed first within a given brain state, then between states of an
ndividual, before comparing between individuals. In order to support experts in better identifying unexpected
ource ratios in a study, they thus need to evaluate four key at-
ributes: (1) brain spatial region, (2) individual, i.e., patient, (3) brain
ctivity state, and (4) time point . Furthermore, through each of
hese analysis stages we found that researchers prefer to maintain
ontext between attributes to better understand sources of varia-
ion. This helped drive our development of a detailed metabolite
atio view that nests within each heatmap cell. Many MRS stud-
es, particularly proof-of-concept research studies, by our collabo-
ators often include around 20 subjects. They may sample up to
our brain regions (although two is more typical), include up to
hree time points, i.e., pre-operative, post-operative, and long-term
ollow-up, and measure either a single or dual brain activity state.
his space of attributes and approximate study size produces a set
f 16 possible case scenarios to account for in our detailed com-
arison view. 
Tier 2 encoding: Detail. Given the low number of key attributes,
e found a simple glyph representing each attribute to be the
ost conducive to user analysis. Our glyph choice and design
as mainly inspired by findings from unit visualization research,
ainly the A tom grammar by Park et al. [20] , for this method’s
emonstrated strong intuition and interaction properties. Since
ur target study sizes are typically relatively small, we avoid issues
ith display and perceptual scalability from which unit visualiza-
ions often suffer. To maintain important context in the analysis
ow, we nest glyphs to mirror the order of analysis preferred
y researchers. Our glyph nesting design was inspired by dimen-
ional stacking visualization techniques pioneered in XmdvTool





























































































































and N-land by Ward et al. [43,44] . Since nested glyphs can form
complex shapes, we chose glyphs that were simple and familiar
to our collaborators to reduce interpretation difficulties. Although
we discussed different stroke styles for glyphs, for simplicity and
clarity our ultimate design uses a solid hairline stroke for each of
the four attributes. Experts felt that changes in stroke weight or
style was distracting and overemphasized elements; this may bias
conclusions. 
The visual design for this detailed view is mapped from a se-
ries of nested ratios. Inside each cell we flatten the data to a sin-
gle voxel array, skipping any duplicate voxels. We then determine
ratios for each of the key attributes, where available, in a nested
fashion that mirrors the preferred order of user analysis: the ra-
tio for each spatial region (using the average of all individuals for
this region), each individual (using the average of all states for the
given individual in a given region), each state (using the average
of all time points for a given state of an individual from a given
region) and each time point, as shown in Fig. 5 (B). These nested
values then map to the appropriate glyph. 
We represent spatial regions as rounded rectangular glyphs.
We chose rounded corners to distinguish spatial glyphs from the
square shape of the heatmap overview cell. Furthermore, the
rounded corners leave space to reveal the heatmap cell color,
thereby subtly preserving context within the detail view. In each
cell, we evenly divide the space vertically by the number of dis-
tinct regions sampled. Individuals are presented as filled disks
when only shown in a single time acquisition (e.g., case 9), ex-
panding to rounded squares when time series data are incorpo-
rated (e.g., case 3). This shape change permits a spark line to move
evenly across the space without going outside the border of the
enclosing glyph. Shapes scale to fill space within their frame. In
instances where different brain activity states are analyzed, we
divide the shape in half horizontally (e.g., case 2). This feature
was important to include for our collaborators who perform time-
resolved spectroscopy, as this is not available in other tools. Finally,
we encode different time acquisitions as points connected via a
spark line, inspired by Meyer et al. in their work, Pathline [45] .
This spark line is nested into the relevant glyph: if a multi time
step series is captured in a study analyzing different brain states,
the spark line is placed within each state half-moon glyph (e.g.,
case 4). If analysis is only for a single activity state, the spark line
nests inside the individual glyph (e.g., cases 3, 11), or inside spa-
tial glyphs for a single patient (e.g., case 7). The remaining cases
comprise different permutations of these spatial region, individual,
brain state, and time point arrangements. 
For example, consider an instance of scenario 16: two patients
are sampled in two regions of the brain four times in a year. Dur-
ing two acquisition times the subjects were asked to perform a
task (active brain state), while the other two times were asked to
relax (resting brain state). This produces a total of 12 unique mea-
surements, 6 per patient. The overview cell is calculated by aver-
aging the 6 values of Gln for patient 1 and the 6 values of NAA for
patient 2, and dividing the result of NAA into Gln. Inside the cell,
we compute this ratio as a series of nested averages for each of
the four key attributes, as depicted in Fig. 5 : (1) spatial region, (2)
individual, (3) brain state, and (4) time point. For each, we average
the metabolite concentrations before computing the ratio. For ad-
ditional detail view images and example tasks of each scenario in
a more complex dataset, we refer interested readers to the supple-
mentary material SpectraMosaic Detail Case Scenarios . 
Hovering facilities display the ratio value for each cell or at-
tribute of interest ( R5 ). Displaying this numerical value provides a
safeguard against possible distortions of color perceptions that may
occur with our chosen glyph nesting structure. This value is dis-
played in red text if one metabolite input exhibits an uncertainty
above 15% (Cramér-Rao lower bound) [46] . This information maye used to assess both the quality of the measurement and the
ccuracy of the spectral processing and quantification steps. 
Tier 3 of MRS data consists of metadata information used for
ontext and selection. We depict this information in a table below
he heatmap. Gender, age, and echo time comprise other important
atient attributes to track because the shape of the spectrum can
ary considerably with these factors—for example, the lactate peak
s virtually undetectable in healthy babies [36] , but is nearly always
easurable in healthy adults with increased neural activation [25] .
cquisition settings are also important, as different echo times will
ield a vastly different spectral representation for the same patient.
. Implementation 
SpectraMosaic is a web-based application implemented with
TML, CSS, Javascript, as well as the D3 [47] , P5, and gridster
avascript libraries. It was developed as a web application to al-
ow for easy integration and use within the hospital network ( R1 ).
 Python back end integrates MATLAB [33] and Tarquin [27] com-
onents in the preprocessing steps. Assets are stored on the
lient and fetched on-demand. Our visualization tool code is open
ource and is publicly available at https://github.com/mmiv-center/
pectramosaic-public . 
. Case study 
We evaluated the utility of SpectraMosaic as a research tool us-
ng a giardiasis MRS case study. Giardiasis is a parasite-borne dis-
ase affecting the small intestine caused by drinking water con-
amination. The metabolic byproducts of this disease are subtle,
ut have been shown to be detectable by MRS [4 8,4 9] . The goal
f this study is to explore and identify possible metabolic indica-
ors for infection using our tool. 
Collected in Bergen, Norway, study data comprised two patients
maged some months apart in three different regions of the brain
t a single echo time (TE 35 ms). For one region (prefrontal region)
wo different TE parameter settings were used (TE 35 ms and TE
44 ms). These data were analyzed by three volunteers recruited
rom the fMRI/MRS research group in Bergen. All three provided
eedback on earlier interfaces of the SpectraMosaic application, and
re not co-authors of this work. User A is an MR physicist special-
zing in development and refinement of spectroscopy protocols for
linical studies of neuropsychiatric and developmental disorders.
ser B, also an MR physicist, uses 31 P- and 13 C-labeled pyruvate
imecourse data to study real-time metabolism. User C is a cog-
itive neuroscientist who uses MRS in conjunction with fMRI in
esearch on neurodegenerative and developmental disorders, e.g.,
arkinson’s disease, stroke, and stuttering. We processed the data
n advance to focus evaluation on the visual web tool; this step
ncluded de-identification of patient-specific information. 
Case workflow feedback . After a brief introduction to the tool,
sers analyzed this case following a “think-aloud” protocol [50] .
e conducted follow-up interviews after the analysis was com-
lete, which we summarize and discuss in this section. 
All three users began with an overview of the spectral graphs
nd voxel position for each imaged brain region ( T1 ). User A
nvestigated spectral graphs by region, while B and C explored by
atient. Users A and B commented that this overview provides an
mportant quality assurance check for each acquisition. Since all
hree users are familiar with MRS, they agreed with our decision
o exclude labeling of spectral peaks; they felt this would have
een unnecessary and distracting to include. All commented that
he hippocampus region spectra looked strange, which could be
ndicative of either a pathology or acquisition problem. They noted
hat this region is particularly difficult to image well, and requires
eeper investigation. 
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Fig. 7. Heatmap inspection in a two-patient, multi-voxel study acquired at two TEs: 
35 ms ( x -axis) and 144 ms ( y -axis). Investigating the Alanine (Ala)/Alanine (Ala) 
cell reveals a higher measurement in the TE 144 ms group. However, the tooltip 









































































































t  All users then explored available group presets and experi-
ented with creation of custom groups for analysis ( T2 ). They
greed that the presets particularly improved the practical usabil-
ty of the tool, stating that these were comprehensive and largely
emoved the need to make custom groups. All users experimented
ith adding a subset of basis set metabolites ( Fig. 3 (D)) to the
eatmap view, although they felt that analysis of all metabolites
s a useful first step for exploring new hypotheses. However, they
greed that subset metabolite analysis is useful as hypotheses are
efined to a narrower metabolite set. 
Feedback was positive for the alphabetical ordering of metabo-
ites on heatmap axes. User C strongly felt that any statistics-based
rdering method would make interpretation too difficult because
hey would spend too much time locating metabolites along the
xes. All users agreed that the representation of metabolite relative
oncentrations as whisker bar or box plots was extremely useful,
s it offered additional insight into unexpected values observed in
he heatmap. User B stated: “Checking the range on the metabolite
nputs helps me as a first check; a huge range could indicate a [brain
egion] area effect or a bad acquisition. I can easily then verify this
y checking the spectral graph in the other panel.” All users noted a
assive range for Gamma-Aminobutyric acid (GABA) in this study,
nd were able to quickly conclude that the acquisition technique
sed is not effective for this metabolite. For this study and others
cquired on the same scanner, through the same technique and pa-
ameters, this representation allows for a straightforward relative
omparison of metabolites before ratio computation ( T3 ). 
In the spectral ratio heatmap, user A was primarily interested
n exploring ratios at different echo times (TE) ( T4 ). We see this
xploration in Fig. 7 ; TE 144 ms voxels are placed on the y-axis
hile TE 35 ms voxels are placed on the x-axis. This user focused
n the diagonal of the matrix, and primarily on examining known
etabolites implicated in giardia infection, e.g., Alanine. Although
his ratio shows relative similarity, we note that the model fit for
his metabolite is outside the accepted range. This requires further
nvestigation. User B also compared different echo times, but over
he entire matrix space for any unexpected dark color regions. For
ach unexpected cell, the user noted whether this could be pathol-
gy, or an acquisition problem. 
All three users were also interested in comparing ratios of
etabolites between patients for each of the three measured brain
egions ( T4 ). They first filtered out TE 144 ms acquisitions, thenrrayed each patient on opposing axes. Assuming both patients are
ealthy, we would expect that the patient glyphs for all spatial re-
ions would show similar values. All three users noted an unex-
ected, relatively large difference for Lactate/Total Creatine in the
ippocampal region ( Fig. 8 ). To investigate this disparity, users A
nd B first verified whether the value met the threshold for each
atient. The value did not meet the threshold for the female pa-
ient, indicating an unreliable fit. Users then reviewed the spec-
ral graph of the hippocampal acquisition for this patient, noting
ts abnormality—users concluded that this merits deeper investiga-
ion, and likely requires an new acquisition. 
Summary feedback . All three participants felt that SpectraMosaic
as useful and could augment their standard workflow for deeper
nsights into spectral data. User A noted that the visual feedback
n the model fit in each ratio provides invaluable data quality in-
ormation. User B stated, “The linking between the glyph ratios, the
pectra, the table, and the images is incredibly useful for us—whenever
e look at metabolite results we always want to go back to the raw
pectra and see if this makes sense, and if the quality is good, and this
akes it really easy to see. I see this tool as being useful to verify as-
umptions I have going in to the study, and to explore the entire range
or quality checks that might affect the results that I’m expecting.”
All participants felt the nested glyphs were integral elements of
he metabolite ratio exploration process. The detail glyph view pro-
ided a means to quickly drill into an unexpected ratio and iden-
ify the possible source(s), while easily retaining contextual infor-
ation from the surrounding heatmap. User C noted: “This [spec-
ral heatmap] overview and detail glyph feature is useful to have a
loser look at, for example, neurodegeneration [in Parkinson’s] with
he loss of dopaminergic connections, as seen with concentrations of
lutamate or GABA... and it is ideal for testing new protocols against
stablished protocols.” Furthermore, experts agreed that the glyph
esign and nesting structure was intuitive and clear in all case sce-
arios, even in larger, more complex studies. All three stated that
nterpreting these glyphs was not difficult, particularly when com-
ared to the very steep learning curve to interpreting spectral data
hrough their standard approach. They agreed that the inclusion
f the legend was helpful when first familiarizing themselves with
he system, but that they had little need to reference it after the
rst few minutes of heatmap exploration. However, two experts
ommented that our mapping of vertical time points could be
caled differently to more clearly demonstrate relative ratio value
hanges, which were at times difficult to recognize. For detailed
xpert feedback on clarity and interpretability of the nested glyph
tructure in all 16 possible case scenarios in a larger dataset, we re-
er interested readers to SpectraMosaic Detail Case Scenarios in the
upplementary material. 
All users indicated interest in an option to extract spectral
eatmap visuals and data for subsequent statistical analysis; user
 expressed interest in seeing this output to the hospital PACS for
ccess by radiologists to aid in more rapid interpretation of spec-
roscopy data for more widespread clinical use. 
. Discussion and limitations 
In the case evaluation of SpectraMosaic we found that our tool
rovides new, interesting insights on metabolic profiles at different
ggregation levels. 
Our task analysis showed that experts were particularly inter-
sted in large metabolite differences. Although our diverging color
apping approach in the heatmap is effective in demonstrating
arge differences between metabolites, subtle differences are less
bvious. Investigation into fine grained color mapping options or
ser-defined color map scaling may help more clearly highlight
hese instances. This extends to our plotting of time points, where
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Fig. 8. Following overview of the metabolite ratios between the individual patients, the user inspects Lactate (Lac)/Total creatine (TCr) ratio between two patients for all 
three regions at TE 35 ms. The user notes a high lactate measurement for the female patient relative to the other measured regions (A). Subsequent inspection of spectral 


























































t  subtle ratio changes could benefit from a logarithmic axis scaling
approach to highlight such changes to users. 
While our decision to sort metabolite inputs in a consistent or-
der limits the ability for pattern recognition within a study, this ap-
proach allows for pattern recognition between studies, where users
can begin to observe a typical “footprint” for certain acquisition
techniques. 
Although this is uncommon for our collaborators, we also note
that if data are not acquired from the same scanner and same pa-
rameters, the utility of the bar and box encoding becomes more
limited. This is because different scanners and different parame-
ters can vastly change the metabolite concentrations; in this case
the ratio heatmap becomes the primary tool for comparative anal-
ysis. 
Our visual design, particularly with reference to the nested
glyphs in the detail view, was guided by collaborative discussions
with research experts. These relatively small study sizes are con-
ducive to nested unit visualizations, and in this iteration of the ap-
plication were not designed to scale to, e.g., hundreds of patients.
With respect to the scalability of groupings within our planned de-
sign, we conducted a preliminary assessment of nested glyph inter-
pretability for each case scenario using a larger study. We provide
the results of this assessment in the supplementary material ( Spec-
traMosaic Detail Case Scenario ). Our collaborators even indicated
that they could envision this approach scaling beyond 20 patients
for some scenarios. Additionally, we could incorporate clustering
or an additional design layer for automatically- or user-generated
groupings for further scalability ( T4 ). 
Lastly, while our glyph system covers all main use cases, we
found that echo time is varied in research studies more often than
initially expected. This frequency of use may imply that this at-
tribute should be encoded at the second priority visualization tier,ather than its current third level. However, comparison of differ-
nt echo times beyond an overview level is of less clinical inter-
st than the four attributes we have discussed. Inclusion of a fifth
lyph would require careful consideration. 
0. Conclusions and future work 
In this design study we contributed a characterization of the
ata, task, and design requirements for the development of Spec-
raMosaic, followed with an expanded tiered visual encoding sys-
em and pipeline. We performed case studies with three domain
xperts to validate our tool in spectroscopy clinical research and
rotocol development. MR spectroscopy is a ripe area for contin-
ed visualization research. 
The flexible design of our tool allows for a number of possi-
le extensions; this may include investigation into additional sta-
istical measures relevant for comparative analysis, e.g., correlation.
lthough this paper focuses on 1 H-MRS, 31 P-MRS and 23 Na-MRS
nalysis may also be integrated to our tool. While we offer ba-
ic mechanisms for uncertainty visualization, exploring additional
eans for uncertainty feedback in the heatmap cells and glyphs
an offer deeper insights into the data. Finally, although typical
RS cohort studies are relatively small, exploration of methods to
xtend our visual encoding system to successfully manage larger
ohorts may further increase tool usability. 
Automatic interface adjustment based on acquisition technique
ffers a valuable investigation of parameter space analysis in MRS.
xploration of the most salient features to reveal for, e.g., PRESS
ersus MEGA-PRESS, may help experts more effectively identify in-
eresting ratios for further investigation. Beyond the medical do-
ain, an additional interesting line of inquiry would be to explore
he adaptability of our abstracted tasks paired with our visual en-
















































































































oding system in other areas facing similar challenges with het-
rogeneous multidimensional data, such as meteorology or geo-
hysics. 
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